Genetic clues for responders to heart failure drug identifiedNews-Medical.netBy Piriya Mahendra, medwireNews Reporter. Researchers have identified genetic signatures that predict which patients respond to the beta blocker bucindolol. Stephen Liggett (U…
Majid Al Futtaim Ventures partners with the Dubai Health Authority to donate … – Al-Bawaba
Majid Al Futtaim Ventures partners with the Dubai Health Authority to donate …Al-BawabaMore than 100 passionate individuals volunteered to give blood in a company-wide blood donation drive organised by Majid Al Futtaim Ventures, the growth engine res…
How overeating leads to diabetes and obesity – Times of India
How overeating leads to diabetes and obesityTimes of IndiaIncreased fatty acids induce inflammation and that, in turn, can further worsen insulin resistance, which is the core defect in type 2 diabetes. Fatty acids also increase glucose production in t…
AstraZeneca launches heart drug `Brilinta` in India – Zee News
Zee NewsAstraZeneca launches heart drug `Brilinta` in IndiaZee NewsAstraZeneca launches heart drug `Brilinta` in India. New Delhi: AstraZeneca Pharma India on Thursday launched its patented antiplatelet drug Brilinta, used to prevent heart attack, afte…
Samsung halts biosimilar rituximab trial on regulatory concerns – In-PharmaTechnologist.com
In-PharmaTechnologist.comSamsung halts biosimilar rituximab trial on regulatory concernsIn-PharmaTechnologist.comThe JV formed through the deal is focused on developing biosimilar versions of marketed products which – evidently – included a version of …
Documentary stirs debate on organ donation – The Copenhagen Post
The Copenhagen PostDocumentary stirs debate on organ donationThe Copenhagen PostThe hospital stated that there is no risk of a false diagnosis of brain death and stressed that people should not worry that their organs will be harvested unless they are …
AstraZeneca launches heart drug 'Brilinta' in India – Economic Times
Moneycontrol.comAstraZeneca launches heart drug 'Brilinta' in IndiaEconomic TimesNEW DELHI: AstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval from the Drug Co…
AstraZeneca launches heart drug in India – Business Standard
AstraZeneca launches heart drug in IndiaBusiness StandardAstraZeneca Pharma India today launched its patented antiplatelet drug Brilinta, used to prevent heart attack, after receiving approval from the Drug Controller General of India (DCGI). Based on …
Churchill will pioneer transplant techniques
OXFORD is to lead the way in developing a new approach to transplant surgery.
Bariatric surgery cuts risk of heart disease – Times of India
Bariatric surgery cuts risk of heart diseaseTimes of IndiaResearchers have revealed that bariatric surgery—restrictive gastric banding and other types of gastric bypass—can radically reduce risk factors for heart disease and stroke, and within a sh…